Education
About Us
Working with TipRanks
Follow Us
Beyond Medical Technologies Inc (TSE:DOCT)
:DOCT
DOCT Stock Chart & Stats
C$0.24
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.24
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.10 - C$0.85
Previous CloseN/A
Volume0.00
Average Volume (3M)29.78K
Market Cap
C$7.54M
Enterprise ValueC$5.95M
Total Cash (Recent Filing)C$7.06M
Total Debt (Recent Filing)C$1.27M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
May 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding32,793,960
10 Day Avg. Volume26,926
30 Day Avg. Volume29,782
Financial Highlights & Ratios
PEG Ratio20.13
Price to Book (P/B)-0.45
Price to Sales (P/S)0.00
P/FCF Ratio-2.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet RecoveryThe restoration of positive equity in the TTM period signals improved solvency and a larger asset base. That durable improvement increases the firm's ability to raise capital, negotiate with creditors and suppliers, and provides a steadier financial foundation to pursue operational recovery over the medium term.
Reduced Cash Burn TrendMaterial progress in reducing negative FCF indicates management has cut costs or improved operational efficiency. A sustained trend toward breakeven cash generation lowers dependency on external financing and meaningfully improves the odds of reaching positive operating cash flow within months to a few quarters.
Structural Industry TailwindsOperating in pollution and treatment controls offers long-term demand driven by regulation, environmental standards and corporate ESG adoption. These structural tailwinds create recurring market opportunities and provide a durable backdrop for revenue recovery if the company can reestablish product-market fit and commercial execution.
Bears Say
No Reported Revenue Since 2022A multi-year absence of revenue eliminates visibility into demand and product-market fit, preventing organic cash generation. Without durable revenue, the business model remains unproven, forcing reliance on financing and raising the risk of dilution, restructuring, or failure unless revenues recur.
Persistent Operating LossesDeep, sustained losses erode capital and limit reinvestment capacity. Continued negative profitability reduces strategic options, undermines credibility with partners and lenders, and means the company must execute material operational or commercial improvements to achieve sustainable margins.
Sharp Rise In Debt And LeverageA rapid increase in debt raises leverage and refinancing risk at a time when operating cash flow is negative and revenue is absent. Higher fixed obligations constrain flexibility, increase interest and default risk, and may force dilutive equity issuance or asset sales, impairing long-term recovery prospects.
Beyond Medical Technologies Inc News
DOCT FAQ
What was Beyond Medical Technologies Inc’s price range in the past 12 months?
Beyond Medical Technologies Inc lowest stock price was C$0.10 and its highest was C$0.85 in the past 12 months.
What is Beyond Medical Technologies Inc’s market cap?
Beyond Medical Technologies Inc’s market cap is C$7.54M.
When is Beyond Medical Technologies Inc’s upcoming earnings report date?
Beyond Medical Technologies Inc’s upcoming earnings report date is May 04, 2026 which is in 72 days.
How were Beyond Medical Technologies Inc’s earnings last quarter?
Beyond Medical Technologies Inc released its earnings results on Nov 26, 2025. The company reported C$0.005 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.005.
Is Beyond Medical Technologies Inc overvalued?
According to Wall Street analysts Beyond Medical Technologies Inc’s price is currently Overvalued.
Does Beyond Medical Technologies Inc pay dividends?
Beyond Medical Technologies Inc does not currently pay dividends.
What is Beyond Medical Technologies Inc’s EPS estimate?
Beyond Medical Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyond Medical Technologies Inc have?
Beyond Medical Technologies Inc has 32,793,960 shares outstanding.
What happened to Beyond Medical Technologies Inc’s price movement after its last earnings report?
Beyond Medical Technologies Inc reported an EPS of C$0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Beyond Medical Technologies Inc?
Currently, no hedge funds are holding shares in TSE:DOCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beyond Medical Technologies Inc
Republic Technologies, Inc. engages in the manufacturing of personal protective equipment. It operates through the following segments: Corporate, PPE Sector, and Waste Treatment. The company was founded by Bharath Bhushan on November 29, 2006 and is headquartered in Vancouver, Canada.
Technical Analysis
Options Prices
Currently, No data available
---